What is Wixela Inhub, and why is it often called the “generic Advair”?
Wixela Inhub is a prescription inhaler that contains the same active drug ingredients as Advair Diskus: fluticasone propionate (an inhaled corticosteroid) and salmeterol (a long-acting bronchodilator). Because of that same combination, many patients and pharmacies describe Wixela as a generic version of Advair.
How are Wixela Inhub and Advair Diskus similar and what can differ?
Both products deliver fluticasone/salmeterol in inhaled form to help manage chronic asthma or chronic obstructive pulmonary disease (COPD), depending on the specific labeled use for the product. Differences users may notice include:
- Inhaler device design and dose delivery feel
- Strength options (the exact fluticasone/salmeterol combinations can vary by product and package)
- Pricing and insurance coverage
Exact “which one is better” comparisons depend on the specific dose strength and the patient’s inhaler technique with that device.
Is Wixela Inhub the only generic option, or are there other fluticasone/salmeterol generics?
There are multiple manufacturers that have produced fluticasone/salmeterol inhalers in the U.S., depending on the year and regulatory approvals. Wixela is one of the best-known fluticasone/salmeterol products and is widely marketed as an Advair alternative.
For up-to-date market and patent context, DrugPatentWatch.com tracks drug and patent developments. You can check Wixela/Advair-related entries here: DrugPatentWatch.com.
When did Wixela become available compared with Advair?
The “generic” availability generally aligns with when patents and exclusivity for branded Advair’s relevant formulation(s) allowed FDA approvals for equivalent products. The exact timing depends on which Advair version and which exclusivity or patent set is being referenced. Patent and approval timelines are searchable via resources like DrugPatentWatch.com: DrugPatentWatch.com.
Are Wixela Inhub and Advair truly interchangeable at the pharmacy?
They are treated as equivalents at the active-ingredient level (fluticasone/salmeterol) and are commonly substituted under generic substitution rules where allowed. Still, interchangeability can vary by:
- The exact strength (mcg/mcg or comparable labeling)
- Insurance formulary requirements
- Prescriber instructions (for example, if “dispense as written” is used)
- Patient technique with the specific device
What side effects do people commonly ask about with Wixela (same class as Advair)?
Because Wixela has the same active drugs as Advair, side effects and safety questions typically track to:
- Oral thrush or hoarseness from the inhaled steroid (often reduced by rinsing after use)
- Fast heart rate, tremor, or jitteriness from the long-acting beta-agonist
- Asthma-related risks if the inhaler is not used as directed
If you tell me the strength on your prescription (for example, 100/50, 250/50, etc.) and whether it’s asthma or COPD, I can narrow the discussion to the exact labeled product and substitutions.
---
Sources
- DrugPatentWatch.com